Journal for ImmunoTherapy of Cancer (Nov 2020)

732 Chemerin reactivates PTEN and suppresses PD-L1 in tumor cells via a novel CMKRL1-mediated pathway

Keith Rennier,
Woo Jae Shin,
Ethan Krug,
Gurpal Virdi

Affiliations

Keith Rennier: Washington University School of Medicine, St Louis, MO, USA
Woo Jae Shin: Washington University School of Medicine, St Louis, MO, USA
Ethan Krug: Washington University School of Medicine, St Louis, MO, USA
Gurpal Virdi: Washington University School of Medicine, St Louis, MO, USA

DOI: https://doi.org/10.1136/jitc-2020-SITC2020.0732
Journal volume & issue: Vol. 8, no. Suppl 3

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal